Trials / Withdrawn
WithdrawnNCT00611065
Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor Imaging
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of California, Irvine · Academic / Other
- Sex
- Male
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The goal is to develop MR imaging techniques to improve delineation of cancer extent, and to improve differential diagnosis between prostate cancer and benign prostate hyperplasia or other benign diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | magnetic resonance imaging | MR contrast agent (0.1 mmol/kg) |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2009-06-01
- First posted
- 2008-02-08
- Last updated
- 2018-07-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00611065. Inclusion in this directory is not an endorsement.